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Abstract
Inherited hypertrichoses are rare syndromes characterized by excessive hair growth that does not result from androgen
stimulation, and are often associated with additional congenital abnormalities. In this study, we investigated the genetic
defect in a case of autosomal recessive congenital generalized hypertrichosis terminalis (CGHT) (OMIM135400) using whole-
exome sequencing. We identified a single base pair substitution in the 59 donor splice site of intron 32 in the ABC lipid
transporter gene ABCA5 that leads to aberrant splicing of the transcript and a decrease in protein levels throughout patient
hair follicles. The homozygous recessive disruption of ABCA5 leads to reduced lysosome function, which results in an
accumulation of autophagosomes, autophagosomal cargos as well as increased endolysosomal cholesterol in CGHT
keratinocytes. In an unrelated sporadic case of CGHT, we identified a 1.3 Mb cryptic deletion of chr17q24.2-q24.3
encompassing ABCA5 and found that ABCA5 levels are dramatically reduced throughout patient hair follicles. Collectively,
our findings support ABCA5 as a gene underlying the CGHT phenotype and suggest a novel, previously unrecognized role
for this gene in regulating hair growth.
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Introduction
Inherited hypertrichosis, first described in the sixteenth century, is
characterized by hair growth that is excessive for the body site and
age of an individual and is independent of androgen stimulation [1],
[2]. These syndromes are categorized as ectodermal dysplasias and
are often associated with additional congenital defects, including
cardiomyopathy, gingival hyperplasia, and craniofacial malforma-
tions [3]. The genetic basis of these syndromes remained largely
elusive until recently, when our group and others reported several
chromosomal rearrangements, copy number variants (CNVs) and
position effects involving genes associated with autosomal dominant,
recessive, sporadic, and X-linked forms of hypertrichosis [4–10].
We previously reported a position effect on the zinc finger
transcription factor TRPS1 in Ambras syndrome hypertrichosis in
humans and the Koala hypertrichosis phenotype in mice, where
Trps1 expression was decreased at the sites of pathology for the
phenotype [5]. More recently, we and others elucidated the
genetic basis of X-linked hypertrichosis [9],[10], resulting from
large interchromosomal insertions on the X chromosome. We
found that a position effect occurs on a distant gene, FGF13,
whose expression was markedly and selectively reduced in patient
hair follicles, suggesting a novel role for this growth factor in hair
follicle growth and cycling [10].
In the autosomal dominant form of CGHT, we identified a
series of duplications of chromosome 17q24.2-q24.3 and reported
a position effect on the SOX9 gene, situated ,1 Mb downstream
of these variants, and found SOX9 expression was markedly
reduced throughout the follicular epithelium of patient hair
follicles [4]. In a separate report of CNVs in the same region of
chromosome 17q24.2-q24.3, four CNVs were identified in several
cases of CGHT [6], with an overlapping minimal region of 555 kb
encompassing four genes: ABCA6, ABCA10, ABCA5, and MAP2K6,
suggesting that disruption of one of these genes may contribute to
the CGHT phenotype. Despite the identification of CNVs and/or
position effects in this region of chromosome 17q24.2-q24.3, no
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point mutations in these or any other single genes have been
described to underlie the CGHT phenotype.
In this study, we investigated the genetic basis of autosomal
recessive CGHT (OMIM135400) in a consanguineous family.
Whole-exome sequencing revealed a novel, rare variant in the 59
donor splice site of intron 32 of ABCA5 that segregates with the
phenotype in a homozygous recessive manner. ABCA5 is highly
expressed in human skin and hair follicles, and its expression
pattern is conserved in mouse tissues as well. Importantly, the
ABCA5 loss-of-function mutation not only leads to a decrease in
protein levels in both mesenchymal and epithelial compartments
of CGHT patient hair follicles, but also to lysosomal dysfunction,
which results in a defective clearance of autophagosomes under
basal conditions and an overall accumulation of endolysosomal
cholesterol in patient keratinocytes. We also identified an
unrelated case of sporadic CGHT with a t3;17 translocation and
cryptic 1.3 Mb deletion spanning ABCA5, and found that ABCA5
levels were dramatically reduced in patient cells as well as
throughout the hair follicle epithelium. Our findings implicate
ABCA5 as a gene with an essential role in hair growth.
Results
Clinical features, histology, and quantification of hair
follicle length in congenital generalized hypertrichosis
terminalis (CGHT)
We ascertained a proband from Yemen with CGHT segregat-
ing with gingival hyperplasia as well as epilepsy. Excessive hair
growth was observed on the face, including the forehead, cheeks,
and upper cutaneous lip, arms, upper and lower back and legs
(Figure 1A). No other members of the patient’s family are affected,
however, the parents of the proband were consanguineous,
suggesting an autosomal recessive mode of inheritance (Figure 1B).
Analysis of patient hair follicles obtained from a whole skin
biopsy of the forearm by hematoxylin and eosin staining
demonstrated that the hairs are of the terminal type since they
were medullated, pigmented and penetrated deep into the dermis
(Figure S1). Patient hair follicles were thicker than those of
controls, and anagen hairs were present in the skin biopsy,
whereas no anagen hairs were detected in control skin biopsies.
We measured the length of the hair shafts from plucked patient
and control forearm hair follicles and found that the patient hair
follicles were significantly longer (87%), with an average length of
29.6 mm (60.9 mm) compared to 15.9 mm (60.6 mm) for
control follicles (P,0.0001) (Figure 1C).
Whole-exome sequencing in CGHT identified a splice site
mutation in ABCA5
To investigate the genetic basis of CGHT in this family, whole-
exome sequencing was performed (Ambry Genetics) on genomic
DNA obtained from the patient as well as both parents. Following
sequencing, bioinformatics analysis (see Materials and Methods)
and filtering on mode of inheritance ultimately lead to the
identification of variants in 26 candidate genes (33 alterations) that
were homozygous in the proband and heterozygous in both
parents (Figure 1D). Further interpretative filtering based on
literature searches focused on genotype-phenotype correlation
revealed three candidate genes with homozygous mutations,
ABCA5, DGKZ, and ZNF253, all of which are not currently
associated with a Mendelian disease, and thus are considered
novel. The nature of the homozygous mutations identified in these
genes includes one splice site mutation (in ABCA5: c.4320+1G.C),
one missense mutation (in DGKZ: c.1678C.T(p.P560S)), and one
deletion (in ZNF253: c.429delA). Segregation analysis of these
mutations revealed that both parents are heterozygous for all three
mutations, whereas neither unaffected sister carries the ABCA5
c.4320+1G.C and DGKZ c.1678C.T(p.P560S) mutations, and
only one unaffected sister carries the ZNF253 c.429delA mutation.
To determine whether these candidate genes are expressed in
the skin and hair follicle, RT-PCR analysis was performed on
RNA isolated from whole skin, which revealed that the ABCA5 and
DGKZ genes are abundantly expressed, suggesting a potential role
for these two genes in the pathogenesis of the CGHT phenotype,
whereas ZNF253 is expressed at lower levels. The function of the
ZNF253 gene is unknown. The DGKZ gene encodes diacylglycerol
(DAG) kinase zeta, a member of the DAG kinase family which
phosphorylates DAG to phosphatidic acid and plays important
roles in lipid signaling implicated in neurological diseases,
including epilepsy, depression and Alzheimer’s disease [11] –
[13]. Moreover, mice deficient in the gene encoding DAG kinase,
epsilon (Dgke) a member of the same gene family, exhibit features
associated with epilepsy [14], suggesting the DGKZ substitution
mutation may contribute to the pathogenesis of the patient’s
seizures. ABCA5, an ATP-binding cassette (ABC) protein, is a
lipid transporter involved in the efflux of cellular cholesterol levels,
and Abca5-deficient mice develop symptoms similar to several
lysosomal diseases of the heart [15], [16]. Interestingly, ABCA5 lies
in the minimal common region to four reported familial cases and
one sporadic case of autosomal dominant CGHT, both with and
without gingival hyperplasia [4] – [6], suggesting that mutations in
this gene may be associated with CGHT.
The ABCA5 mutation results from a G-to-C substitution in the
first nucleotide of intron 32 (Figure 1E). Sanger sequencing was
performed on genomic DNA from the proband as well as the
unaffected father, which confirmed homozygosity in the proband
(II-2) and heterozygosity in the father (I-2) for the c.4320+1G.C
mutation (Figure 1 E, F). Importantly, this mutation was not
present in control individuals, determined by searching various
genome databases and sequencing the genomic DNA of 10 control
individuals. Moreover, a query for genetic variants that lie within
Author Summary
Inherited hypertrichoses represent a group of hair over-
growth syndromes that are extremely rare in humans and
have remained an area of great interest to evolutionary
geneticists since they are considered to be recurrences of
an ancestral phenotype. These syndromes often present
with additional congenital abnormalities including bone,
heart and dental defects; thus, it is crucial to identify the
mechanisms and genes underlying the pathology. Copy
number variants (CNVs) have previously been reported in
several cases of congenital generalized hypertrichosis
terminalis (CGHT) with a minimal overlapping region of
555 kb encompassing four genes. However, no point
mutations in these or any other single genes have been
described to underlie the CGHT phenotype. In this study,
we report the first loss-of-function mutation in an ABC
transporter, ABCA5 and identified an additional copy
number variant in a separate case that lies within the
minimal common region. We found high levels of ABCA5
expression in both epithelial and mesenchymal compart-
ments of human and mouse hair follicles, and in CGHT
patients, this expression is significantly reduced or
completely lost. ABCA5 is a lysosomal protein, and its
loss-of-function compromises the integrity of lysosomes
and leads to an intra-endolysosomal accumulation of
cholesterol. Importantly, our findings support a novel role
for ABCA5 in regulating hair growth.
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the ABCA5 locus using the UCSC Human Genome (hg19) and
Ensemble Genome Browsers verified that this variant is not a SNP
or common variant associated with any human genetic disease.
Thus, the c.4320+1G.C mutation in ABCA5 is novel.
In light of the cosegregation of the mutation with the disease
phenotype in the family, association with the CGHT phenotype in
previously reported cases, and reported expression in the human
hair follicle with ABCA5 mRNA levels being the highest out of the
four genes within the minimal common region [6], we further
investigated the consequence of this mutation on ABCA5 mRNA
splicing and the potential role for this protein in hair follicle
growth.
Sequencing of the mutant ABCA5 transcript revealed
aberrant splicing
In silico analysis of splicing events using the computational
algorithms Berkley Drosophila Genome Project (BDGP) [17] and
ESEfinder [18], [19] predicted that the c.4320+1G.C mutation
results in complete loss of the donor splice site. To determine the
consequence of the mutation at the transcript level, we amplified
by RT-PCR the ,200 bp region flanking the mutation from
patient, carrier, and control mRNA. Sanger sequencing revealed
that the mutation leads to aberrant skipping of exon 32 in the
proband (Figure 2A). As a result of joining exon 31 to exon 33, the
remainder of the transcript downstream of the mutation is out-of-
frame, leading to a premature termination 14 bp downstream of
the mutation (Figure 2A). RT-PCR analysis of the exon 31–33
amplicon using RNA isolated from whole skin revealed the
complete absence of the wild-type transcript in the proband. In
contrast, we found the presence of the wild-type transcript at high
levels and the mutant transcript at very low levels in the father
(Figure 2A). The mutant mRNA most likely undergoes nonsense-
mediated decay, since the mutation resides near the 39 end of the
transcript and the aberrant splicing event is predicted to affect the
overall stability of the mRNA.
To investigate this possibility, we compared the relative ABCA5
mRNA levels between the proband and unaffected carrier father
by qRT-PCR using primers located at the 59 end of the mRNA,
and found that transcript levels were significantly reduced in
patient whole skin (2.7-fold; p,0.0001), cultured keratinocytes
(2.8-fold; p=0.0016), as well as fibroblasts (4.9-fold; p,0.0001),
demonstrating that the mutant mRNA is unstable and undergoes
nonsense-mediated decay (Figure 2B).
ABCA5 is abundantly expressed in the epithelial and
mesenchymal lineages of human and mouse hair follicles
While ABCA5 expression was previously identified in plucked
human hair follicles by RT-PCR analysis [6], the specific cell
type(s) synthesizing ABCA5 in the hair follicle and potential
expression in the surrounding dermal tissue remained unknown.
Using in situ hybridization on human hair follicles in the growth
phase of the hair cycle (anagen), we observed ABCA5 transcript
expression in both the epithelial and mesenchymal compartments,
present within the outer root sheath (ORS) of the hair follicle as
Figure 1. Whole-exome sequencing in a case of congenital generalized hypertrichosis terminalis (CGHT) revealed a splice site
mutation in ABCA5. (A) Clinical photos of proband that illustrate the excessive hair overgrowth on the back (upper photo) and leg (lower photo).
The proband is two years of age in this photo. (B) Pedigree of the family from a consanguineous union (indicated by double lines), where the
proband (arrow) is the only affected member. Asterisks indicate the individuals on whom whole-exome sequencing was performed. (C) Quantification
of the length (mm) of patient versus control hair follicles derived from the forearm revealed that patient hair follicles are 87% longer, with an average
length of 29.6 mm (60.9 mm) compared to 15.9 mm (60.6 mm) for control follicles (***P,0.0001). (D) Whole-exome sequencing filtering strategy,
including the number of alterations and genes obtained at each level. One alteration (c.4320+1G.C) was identified in the ABCA5 gene, and
cosegregation analysis in the family members revealed that both parents are carriers of this mutation, whereas the two unaffected sisters do not carry
this mutation. (E) View of ABCA5 (red) and the surrounding genes (black boxes) on chr17q24.2-q24.3, where arrows indicate direction of transcription.
A magnified view of the c.4320+1G.C mutation in exon 32 of ABCA5 with the exon 32-intron 32 boundary reference sequence annotated in colors
corresponding to sequencing peaks. The G.C substitution is indicated below the control sequence. (F) Sequencing of control, carrier, and affected
genomic DNA confirmed heterozygosity for the c.4320+1G.C mutation (boxed) in the father (I-1) and homozygosity in the proband (II-1). All
coordinates reference the UCSC Genome Browser human reference genome hg19.
doi:10.1371/journal.pgen.1004333.g001
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well as dermal sheath (Figure 2C). To determine the localization
pattern of ABCA5 protein in human skin and hair follicles,
immunohistochemistry (IHC) was performed on paraffin-embed-
ded skin sections and expression was most evident in the dermal
sheath, perifollicular dermis, ORS, and IRS of hair follicles
(Figure 2 D–F). Since the ABCA5 antibody is polyclonal, we
validated endogenous ABCA5 expression in the hair follicle as well
as in the surrounding perifollicular dermis using RT-PCR on these
tissues and observed strong ABCA5 expression in plucked hair
follicles (HF), microdissected ORS, as well as perifollicular dermis
(FD) including the dermal sheath (Figure 2G).
To assess whether the human ABCA5 expression pattern was
conserved in mouse skin and hair follicles, we first determined
whether we could detect Abca5 immunoreactivity in a site of
known Abca5 expression using the same polyclonal antibody. In
mice and rats, Abca5 mRNA levels are abundant in the testis by
Northern blotting and in situ hybridization [20], [21]. Using
immunohistochemistry and immunofluorescence staining on adult
mouse testis sections, we observed strong localization of Abca5 to
the basal cells of the seminiferous tubules, interstitial cells
consisting of Leydig cells (as previously reported in [21]), as well
as the tunica albuginea (Figure S2 A–B, G). In the epididymis, we
found very strong and specific localization of Abca5 to the
connective tissue outlining the cylindrical epithelium in the corpus
and cauda regions, including fibrocytes and smooth muscle cells,
as well as within the basal and tall columnar cells of the corpus
cylindrical epithelium (Figure S2 D–E, H–I). The control testis
and epididymis sections (no primary antibody) yielded no signal
(Figure S2 C, F). Importantly, we observed the same localization
pattern of Abca5 in these tissues using two different fixatives; an
organic solvent (methanol/acetone) and cross-linking agent
(formalin), and our data are consistent with previous reports on
Abca5 mRNA expression [20], [21].
We next investigated the localization pattern of Abca5 in the
mouse anagen hair follicle using immunofluorescence staining and
immunohistochemistry, and observed high levels of Abca5
localization to the ORS and IRS of hair follicles (Figure S3).
Expression was also observed in the dermal sheath and
perifollicular dermis by the immunohistochemistry method (Figure
S3 E–F), similar to what we observed in human hair follicles
Figure 2. The ABCA5 c.4320+1G.C mutation leads to aberrant splicing and nonsense mediated decay, and ABCA5 is abundantly
expressed in the skin and hair follicle. (A) Depiction of normal splicing between exons 31 and 32 (black lines) and aberrant skipping of exon 32
as a result of the c.4320+1G.C mutation (red lines), where the adjoining of exon 31 to 33 leads to premature termination during translation. The out-
of-frame exon 33 sequence (red box) is indicated by the hatched lines, followed by a stop codon. Sequencing of the mutant transcript (MT) confirmed
the aberrant splicing event, where the amino acid sequence is listed above and the stop codon is indicated by an asterisk. RT-PCR on RNA from whole
skin followed by gel electrophoresis of the exon 31–33 amplicon demonstrates complete loss of the wild-type (WT) transcript in the patient (P), and
very low levels of the mutant (MT) transcript in the carrier (C). (B) qRT-PCR of ABCA5 transcript levels in the carrier and patient revealed a significant
reduction of levels in patient whole skin, keratinocytes and fibroblasts. A Student unpaired t test was performed with a cutoff P value of 0.05 for
statistical significance. (C) ABCA5 is expressed at strong levels throughout the outer root sheath (ORS) and dermal sheath (arrow) of the human hair
follicle by in situ hybridization using an antisense probe, whereas the sense probe produced minimal background signal. (D) ABCA5 localizes to the
perifollicular dermis, dermal sheath, as well as the hair follicle ORS and inner root sheath (IRS) by immunohistochemistry on paraffin-embedded
sections. (E) The anti-rabbit IgG primary antibody control produced no signal. (F) Immunohistochemistry of ABCA5 on hair follicle end bulbs revealed
strong expression in the dermal sheath and perifolliclar dermis but no expression was observed in the dermal papilla. (G) ABCA5 is endogenously
expressed in plucked scalp hair follicles, microdissected ORS, as well as perifollicular dermis (including dermal sheath), determined by RT-PCR.
Expression was normalized to GAPDH levels. M = marker.
doi:10.1371/journal.pgen.1004333.g002
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(Figure 2D). Importantly, ABCA5 localization in the skin and hair
follicle appears to be conserved between human and mouse, and
its broad expression pattern spans multiple cell lineages, both
within and surrounding the hair follicle. Collectively, these data
suggest a prominent, evolutionarily conserved role for this
transporter in regulating hair growth.
Homozygous loss-of-function of ABCA5, an N-
glycosylated protein
To determine the consequence of the ABCA5 c.4320+1G.C
mutation at the protein level, we performed immunofluorescence
staining on control and CGHT keratinocytes cultured from whole
skin biopsies, and observed a striking reduction in ABCA5
localization (Figure 3A). Immunoblotting revealed the loss of a
215 kDa band corresponding to the full-length transporter in its
glycosylated form, as well as a 187 kDa band, representing the
unglycosylated form [15] (Figure 3B). While the full-length
transporter was predominantly detected in keratinocytes, in
fibroblasts, we observed the expression of a previously reported
truncated variant [20] that produces a half-transporter and a
,100 kDa band. Importantly, the band representing this trun-
cated variant was not detectable in CGHT patient fibroblasts
(Figure S4). Since ABCA5 is a reported glycoprotein possessing
multiple sites for N-glycosylation, we investigated whether the
c.4320+1G.C mutation abolished the glycosylated form of the
protein in patient fibroblasts by incubating total protein in the
presence or absence of the PNGaseF enzyme that removes all N-
glycosyl modifications. Following immunoblotting, we observed
that the band corresponding to the ,100 kDa isoform that is
absent in the proband represents the glycosylated form of the
protein (Figure S4). Since glycosylation is an important post-
translational modification crucial to the proper folding, stability,
subcellular localization and/or even function of many lysosomal
proteins, including ABC transporters [22], this finding suggests a
loss-of-function of both the full- and half-transporters encoded by
ABCA5 in CGHT.
Lastly, to evaluate the consequence of the c.4320+1G.C
mutation on ABCA5 protein localization at the tissue level, we
performed immunofluorescence staining on patient and control
hair follicles and observed a striking reduction of ABCA5 protein
throughout the outer and inner root sheaths of patient hair follicles
in catagen and anagen (Figure 3C). Importantly, loss of ABCA5
expression at the site of pathology for the phenotype further
demonstrates that the c.4320+1G.C mutation results in a
complete loss-of-function allele.
ABCA5 loss-of-function in CGHT keratinocytes perturbs
endolysosomal function
Lysosomes have been reported to play a role in hair cycling,
where mice deficient for lysosomal proteases, cathepsin L (Ctsl)
and lysosomal acid phosphatase 2 (Acp2), have delayed progres-
sion through the hair cycle resulting in periodic hair loss that is
characterized by hyperproliferation of epithelial cells in the hair
follicle and basal layer of the epidermis [23] – [26]. In mice,
Abca5-deficient cells have aberrant processing of autolysosomes
and autophagosomes [15], suggesting a role in lysosome integrity
and/or autophagy, a catabolic process of intracellular digestion
and recycling of organelles [27]. To gain insight into whether
CGHT patient cells possessed intrinsic autolysosomal and/or
autophagic defects, we visualized key markers of these organelles
at the cytological level. LC3, a well-established marker for
autophagosomes, is converted from its cytosolic form (LC3-I) to
a lipidated form (LC3-II) which is able to re-localize and bind
specifically to autophagosomal membranes [27]. A large pool of
LC3-II is degraded upon lysosome-autophagosome fusion, when
the internal content of autophagosomes is destroyed by lysosomal
hydrolases. Immunofluorescence staining against endogenous LC3
revealed an increased number of LC3-positive particles (i.e.,
autophagosome-like structures) in the affected keratinocytes
compared with control, suggesting defects in the autophagy
pathway (Figure 4A).
In order to discriminate between higher levels of basal
autophagy and a defective clearance of autophagosomes, bafilo-
mycin A1 (BAF), a proton pump inhibitor that blocks the
acidification of lysosomes and thus the clearance of autophago-
somes, was added to growing cells 2 hours prior to fixation. BAF
treatment caused a 2-fold increase in the number of LC3-positive
puncta representing autophagosomes and autophagolysosomes in
control keratinocytes, compared to untreated keratinocytes
(Figure 4A, Figure S5A). In contrast, BAF treatment failed to
significantly increase the number of LC3-positive particles in the
patient keratinocytes compared to untreated cells (Figure 4A,
Figure S5A). Furthermore, immunofluorescence staining against
p62, a polyubiquitin binding protein as well as an autophagic
cargo, revealed a strong accumulation of puncta in patient
keratinocytes, further suggesting autophagy defects (Figure 4A,
Figure S5B). Overall, these results indicate that ABCA5 loss-of-
function in CGHT causes defects in the autophagy pathway, and
more specifically, point to an impairment in the clearance of
autophagosomes and autophagic flux under basal conditions.
These results also suggest that the mechanism underlying the
autophagy defects caused by the ABCA5 mutation is a decrease in
lysosomal function.
Because a previous report has shown a role for ABCA5 in the
efflux of cholesterol in macrophages [16], we next tested whether
patient cells exhibit defects in the metabolism and/or transport of
free cholesterol. Additionally, because ABCA5 is localized to the
lysosomal compartment, its mutation may affect the handling of
lipoprotein-derived cholesterol in the endolysosomal system,
perhaps contributing to the dysfunction of these organelles in
patient cells. In order to visualize cholesterol, cells were stained
with filipin, a polyene macrolide antibiotic and antifungal that
fluoresces and detects unesterified free cholesterol [28]. Remark-
ably, the mutation in ABCA5 produced an increase in intracellular
filipin staining compared to controls (Figure 4B, top panel). More
specifically, filipin-positive puncta were observed mostly inside
Lamp1-positive structures (Figure 4B, lower panel) suggesting an
accumulation of free cholesterol in the lumen of endolysosomal
organelles, likely in their intraluminal vesicles. These data suggest
that ABCA5 controls the fate of lipoprotein-derived cholesterol
and that its mutation alters the intracellular traffic of free
cholesterol, somewhat reminiscent of phenotypes observed in
lysosome storage disorders, such as Niemann Pick disease Type C
[29].
Cytogenetic analyses and breakpoint mapping in a
sporadic CGHT case revealed a t3;17 translocation and
cryptic 1.3 Mb deletion encompassing ABCA5
At around the same time we identified the ABCA5 c.4320+1G.
C mutation in homozygous recessive CGHT, we independently
studied this candidate region of chromosome 17 in a sporadic case
of hypertrichosis. We ascertained a patient from Mexico with
hypertrichosis universalis congenita (OMIM145700), whose par-
ents (nonconsanguineous union) and siblings were unaffected. The
patient exhibited excessive overgrowth of terminal hairs on the
extremities, back, chest, and the face. Moreover, histological
analysis of patient hair follicles obtained from a skin biopsy of the
ABCA5 Cholesterol Transporter in Hair Growth
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lower back revealed the presence of large anagen hair follicles that
penetrate deep within the dermis (Figure S6).
We initially performed karyotype analysis using G-banding of
metaphase chromosomes that revealed a translocation between
chromosomes 3q12 and 17q25, while the other chromosomes
appeared cytogenetically normal. Chromosomal paint with two
FISH probes against chromosomes 3 and 17 verified that no
other chromosomes were involved in this rearrangement
(Figure 5A), and telomere FISH (Figure S7A) confirmed that
no subtelomeric sequences were lost as a result of the
chromosome 17 breakpoint near the q telomere, suggesting an
apparently balanced translocation event. To test whether this
rearrangement segregated in the family, karyotype analysis was
performed on both parents and siblings of the patient, but no
abnormalities were detected, suggesting a de novo chromosomal
rearrangement.
We next performed FISH analysis using BAC clones, which
revealed a cryptic deletion at the breakpoint of chromosome 17,
spanning BAC clones RP11-387O17 (chr17:66,354,485-
66,568,819) and RP11-293K20 (chr17:67,076,187-67,261,438)
(Figure S7B, C). To fine-map the deleted region, we utilized the
Affymetrix 2.7M SNP array, which defined an 849.4 kb cryptic
breakpoint deletion on chromosome 3p12.2 which did not contain
any annotated genes, as well as a 1.3 Mb deletion on chromosome
17q24.2-q24.3 (Figure 5B) that encompassed 7 Ref Seq genes:
members of the superfamily of ATP-binding cassette (ABC)
transporters (ABCA8, ABCA9, ABCA6, ABCA10, ABCA5), mito-
gen-activated protein kinase kinase 6 (MAP2K6) and potassium
Figure 3. ABCA5 protein levels are significantly reduced in CGHT patient keratinocytes and hair follicles. (A) Immunofluorescence
staining on cultured keratinocytes revealed a dramatic decrease in ABCA5 localization in CGHT keratinocytes compared to control (B)
Immunoblotting on protein extracted from control and patient keratinocytes demonstrated loss of a 215 kDa band, which corresponds to the
glycosylated form of the full-length ABCA5 protein, as well as a 187 kDa band, which is the unmodified protein in the patient compared to control.
(C) Loss of ABCA5 localization to the outer root sheath (ORS) and inner root sheath (IRS) within patient hair follicles by immunofluorescence staining.
Affected hair follicles in anagen and catagen were obtained from forearm skin biopsies, and control catagen hairs were obtained from forearm skin
and anagen hairs from the occipital scalp. The anti-rabbit IgG primary antibody control produced no signal. HS = hair shaft; DP = dermal papilla; DS
= dermal sheath.
doi:10.1371/journal.pgen.1004333.g003
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inwardly-rectifying channel J16 (KCNJ16). We confirmed the
1.3 Mb deletion with quantitative PCR (qPCR) on patient and
control genomic DNA using primers specifically designed to
amplify sequences flanking and within the deleted region
(Figure 5C). To determine whether the translocation event
resulted in the disruption of a gene, we searched for transcripts
that mapped to the vicinity of the breakpoints using the Genome
Browser available at the UCSC database (hg19) and subsequently
cloned the breakpoints, which did not reveal any evidence for gene
disruption.
The cryptic 1.3 Mb deletion at chr17q24.2-24.3 leads to a
position effect on the downstream gene, SOX9
Several cases of CGHT have been reported in which CNVs on
chr17q24.2-24.3 that lie within a 2.4 Mb region (Figure S8) have
been identified and hypothesized to cause a position effect on the
SOX9 gene, a well-defined regulator of hair follicle stem cells [30],
[31], which resides 1-2 Mb downstream of these variants. In our
previous report of an autosomal dominant CGHT case, we found
SOX9 expression was dramatically reduced throughout the hair
follicles of patients who possess duplications within the
chr17q24.2-24.3 region [4]. To investigate the possibility that
the 1.3 Mb deletion identified in the present study led to altered
SOX9 expression, we performed qRT-PCR on RNA isolated from
patient and control keratinocytes and observed decreased SOX9
expression in the patient keratinocytes by approximately 2.5-fold
(P.0.001) (Figure 5D). This result is consistent with our previous
findings, suggesting a contribution of decreased SOX9 expression
levels to the excessive hair overgrowth phenotype of CGHT.
Given the association of SOX9 with CGHT and its known role
in regulating hair follicle stem cells and outer root sheath
differentiation [30], [31], we investigated the consequence of
ABCA5 loss-of-function on SOX9 transcripts in the autosomal
recessive CGHT case. Using qRT-PCR on patient and control
keratinocytes, we did not detect a significant difference in SOX9
gene expression (data not shown). While it remains possible that
SOX9 acts upstream of ABCA5, these genes may reside in separate
pathways and utilize distinct mechanisms to contribute to the
CGHT pathology.
ABCA5 mRNA and protein levels are dramatically reduced
in both epithelial and mesenchymal compartments of
the skin and hair follicle in sporadic CGHT
Since the 1.3 Mb deletion we identified encompasses the
ABCA5 locus, and both sporadic and autosomal recessive CGHT
patients possess excessive overgrowth of terminal hairs, we next
investigated the possibility that the second allele in the sporadic
CGHT case may harbor a mutation in the ABCA5 gene.
Therefore, we sequenced all the exons of ABCA5 and ,2 kb
upstream of the gene, but did not find any mutations (data not
shown). To test ABCA5 mRNA expression levels in the sporadic
CGHT case, we performed qRT-PCR in keratinocytes and
fibroblasts cultured from a patient skin biopsy compared to
control, and observed a 3.7-fold decrease in ABCA5 transcript
levels in patient keratinocytes (p,0.0001), and a 2.4-fold decrease
in patient fibroblasts (p,0.0001) (Figure 6A). Immunoblotting in
fibroblasts cultured from patient and control skin biopsies
revealed a striking decrease in ABCA5 protein levels, and
treatment with the N-glycosylase PNGaseF revealed loss of the
glycosylated form of the protein (Figure 6B). Moreover, we found
using immunofluorescence staining on patient and control hair
follicles in catagen and anagen that ABCA5 protein levels were
Figure 4. Homozygous loss-of-function of ABCA5 perturbs lysosome function, resulting in an overall accumulation of
autophagosomes and intracellular cholesterol levels in CGHT keratinocytes. (A) Control and CGHT keratinocytes were cultured in normal
media in the presence or absence of 50 nM bafilomycin, fixed and immunostained. Confocal analysis of LC3 (green), Lamp1 (red) and p62 (blue)
revealed an increased number of LC3-positive particles as well strong accumulation of p62 particles in affected keratinocytes. BAF-treated control
cells possessed a two-fold increase in the number of LC3 puncta, whereas no significant difference was observed in BAF-treated affected cells
(quantified in Figure S5). (B) Control and CGHT keratinocytes were fixed and immunostained for Filipin and Lamp1 (red), which revealed an
accumulation and redistribution of free cholesterol to Lamp1-positive organelles in affected keratinocytes.
doi:10.1371/journal.pgen.1004333.g004
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dramatically reduced throughout the outer and inner root sheath
of the patient hair follicles (Figure 6C). Collectively, these results
suggest that loss of one genomic copy of ABCA5 and its
surrounding regulatory elements severely disrupts expression
from the other allele, and significantly reduces expression levels,
suggesting haploinsufficiency of ABCA5 in the sporadic case of
CGHT.
Discussion
In this study, we investigated the genetic basis of a case of
CGHT using whole-exome sequencing and identified a homozy-
gous recessive loss-of-function mutation in a donor splice site of
ABCA5 that cosegregates with the phenotype. The c.4320+1G.C
mutation leads to loss of ABCA5 expression and localization within
patient keratinocytes, fibroblasts and hair follicles compared to
controls. We found that endogenous ABCA5 is highly expressed in
both epithelial and mesenchymal compartments of the hair follicle,
and that its homozygous recessive loss-of-function is associated
with defective lysosomes, as well as an overall accumulation of
autophagosomes and endolysosomal cholesterol. In a case of
sporadic CGHT, we performed detailed cytogenetic analyses,
breakpoint mapping, CNV analysis and expression studies, which
revealed a 1.3 Mb deletion encompassing the ABCA5 locus and
markedly reduced ABCA5 levels in patient cells and hair follicles.
In inherited hypertrichoses, the mechanism(s) that lead to an
excessive hair overgrowth phenotype observed include an
increased anagen duration, increased hair follicle density, as well
as a vellus-to-terminal transformation, where fine, unpigmented
and unmedullated hairs are stimulated to grow deeper into the
dermis, widen, and become medullated as well as pigmented [1],
[2]. In the case of CGHT, a condition that is present at birth,
Figure 5. Cytogenetic analyses, breakpoint mapping, and copy number variant analysis in a sporadic case of CGH revealed a t3;17
translocation that leads to a cryptic 1.3 Mb deletion of chr17q24.2-24.3, and SOX9 expression is reduced in patient keratinocytes.
(A) Chromosomal paint was performed in a sporadic case of CGHT with commercially available whole chromosome probes for both chromosomes 3
and 17. Note: the probes do not bind to any of the other chromosomes except 3 and 17, and the derivative chromosomes suggesting that this is an
isolated rearrangement between these two chromosomes. DAPI staining was used to visualize the entire chromosomal set (blue). (B) Copy number
variant analysis using the Affymetrix Cytogenetics Whole Genome 2.7M array validated the cryptic deletion that spans 1.3 Mb (red box). RefSeq genes
are depicted as black boxes. (C) Region of chr17q24.2-q24.3, including the genes and 1.3 Mb deletion identified by FISH and CNV analysis. The
quantitative PCR (qPCR) amplicons are indicated as vertical lines, with three amplicons residing within and two flanking the deletion. qPCR was
performed to confirm the deletion on control (C) and affected (A) genomic DNA using relative quantification and the primers listed in the Materials
and Methods. (D) qRT-PCR of SOX9 on RNA from control and affected keratinocytes revealed a 2.5-fold decrease (P.0.001) in expression in patient
keratinocytes. A Student t test (unpaired) was performed with a cutoff P value of 0.05 for statistical significance. All coordinates reference the UCSC
Genome Browser human reference genome hg19.
doi:10.1371/journal.pgen.1004333.g005
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terminal hairs develop at sites of the body where vellus hairs
should be, a developmental event that most likely occurs during
late hair follicle morphogenesis or immediately following. Lanugo
hairs shed in utero and then replaced by vellus hairs are instead
replaced with terminal hairs. In addition to a vellus-to-terminal
transformation, it is likely that the excessive hair overgrowth
phenotype in CGHT is also contributed by an increased duration
of anagen, as the hairs produced across the body are longer than
what is considered normal for the age, race, and gender of the
individual. In the autosomal recessive CGHT case in this study,
we found that the length of hair follicles plucked from the forearm
was significantly greater than that of control hair follicles.
Moreover, histological analysis of patient skin biopsies from
extensor skin of the extremities revealed the presence of large
anagen hair follicles situated deep in the dermis, whereas hair
follicles in anagen were not present in control skin biopsies.
Using several methods of detection, we found that ABCA5 is
strongly expressed in both mesenchymal and epithelial lineages of
the human hair follicle. In mouse hair follicles, we observed the
same expression pattern as in human follicles, and using
immunostaining with a polyclonal ABCA5 antibody, detected
Abca5 localization in the testis and epididymis—positive sites of
Abca5 mRNA expression. In the skin, the mesenchymal expres-
sion (perifollicular dermis, dermal sheath) appears more intense
using formalin-fixed paraffin embedded (FFPE) samples, and the
epithelial outer and inner root sheath expression is more intense
using frozen sections. These differences are most likely artifacts of
antigen accessibility and tissue preservation (organic solvent vs.
cross-linking agent) between the two methods (i.e. dermal and
subcutaneous tissue is better preserved in the FFPE sections).
However, RT-PCR analysis and in situ hybridization demonstrated
strong ABCA5 expression in both epithelial and mesenchymal
lineages, and negative controls for both mRNA and protein studies
yielded no signal.
High levels of ABCA5 localization to the hair follicle IRS is
intriguing, as several genes involving lipid metabolism or transport
possess strong inner root sheath expression and have been
described to underlie human genetic conditions with sparse hair.
P2RY5, encoding an orphan G protein-coupled receptor, is
mutated in patients with autosomal recessive wooly hair syndrome
Figure 6. ABCA5 levels are markedly reduced in patient hair follicles of the sporadic CGHT case. (A) qRT-PCR for ABCA5 on control and
affected keratinocytes and fibroblasts cultured from whole skin biopsies revealed a significant reduction in the patient cells compared to controls. A
Student unpaired t test was performed with a cutoff P value of 0.05 for statistical significance. (B) Immunoblotting on protein extracted from carrier
and patient fibroblasts in the presence or absence of the enzyme, PNGaseF revealed loss of a ,100 kDa band that is the glycosylated form of the
protein in patient fibroblasts relative to controls. (C) Immunofluorescence staining on control and patient hair follicles in the catagen and anagen
stages demonstrated reduced ABCA5 localization throughout the outer root sheath (ORS) and inner root sheath (IRS) of patient hair follicles (compare
to control catagen hair follicle in Figure 3C). HS = hair shaft; HC = hair canal.
doi:10.1371/journal.pgen.1004333.g006
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[32], [33]. Likewise, LIPH encodes the phospholipase A1 family
member that converts phosphatidic acid into lysophosphatidic
acid, and is mutated in patients with autosomal recessive wooly
hair and hypotrichosis [32] – [34]. While the precise mechanism
by which these genes control hair growth remains elusive, we
postulate that the loss of a functional ABCA5 transporter in the
IRS of patient hair follicles may contribute to excessive hair
overgrowth through blocking cholesterol efflux.
Human ABCA5 is also highly expressed in perifollicular dermal
tissue, including the dermal sheath of the hair follicle, and the
number of dermal papilla cells has been shown to be important in
determining hair follicle size in mice [35]. Since patient hair
follicles are larger and longer, we postulate that they may contain
an increased number of dermal papilla cells, but were unable to
directly test this using the skin biopsies we received. Additionally,
the control of hair follicle size is linked to BMP levels in the skin,
where mice overexpressing the BMP antagonist, Noggin, have
enlarged anagen hair follicles [36]. Therefore, ABCA5 transport of
cholesterol may normally limit hair growth and intersect with the
BMP signaling pathway, such that in ABCA5-deficient hair
follicles, the excess buildup of intra-endolysosomal cholesterol
attenuates BMP signaling and recapitulates the enlarged hair
follicle phenotype of the Noggin overexpression mouse model.
Functional studies using Abca5-/- mice would be required to
directly address this.
ABCA5 has not previously been described to be associated with a
human condition, particularly one manifesting a hair or skin
phenotype. In humans, ABCA5 is a reported biomarker for tumor
stem cells in osteosarcoma based on its overexpression, where it is
also highly expressed in melanoma and undifferentiated colon and
ovarian carcinomas [37] – [39]. Consistent with the reported role
of ABC transporters in tumor biology conferring resistance to
drugs and chemotherapy/cancer-related substrates (i.e. phospho-
lipids and cholesterol) [40], ABCA5 upregulation may protect
undifferentiated tumor cells from an intracellular accumulation of
cholesterol and other sterols.
Mutations in ABC transporters have been reported in several
other genetic skin diseases, including ABCA12 in lamellar
ichthyosis type 2 as well as the severe and lethal ichthyosis,
Harlequin ichthyosis, ABCC9 in Cantu´ syndrome, and ABCC6 in
the connective tissue disorder pseudoxanthoma elasticum (PXE)
[41] – [46]. ABCA12 is expressed in the skin and its deficiency
leads to abnormal lipid transport in keratinocytes, effectively
compromising the skin barrier in a cell-autonomous manner [46].
Recently, dominant missense mutations have been reported in the
ABC transporter gene, ABCC9 in several cases of Cantu´ syndrome,
a form of congenital hypertrichosis segregating with osteochon-
drodysplasia, distinctive facial features, as well as cardiac defects
[44], [45]. The ABCC9 gene encodes a transmembrane protein
that is a constituent of a potassium channel complex, and
electrophysiology experiments revealed that the missense muta-
tions have gain-of-function or activating effects on the protein, as
they reduce ATP-dependent inhibition of the channel [44].
Interestingly, the ABCC6 gene encodes the multidrug resistance
associated protein 6 (MRP6), and is exclusively expressed in the
liver and kidney, suggesting that mutations lead to ectopic
mineralization within the skin of PXE patients via a non cell-
autonomous mechanism [47]. Importantly, this suggests that
blocking the allocrite, or transported substrate, is the key
determinant of the phenotype, because ABCC6 itself is not
expressed in the skin, yet its loss-of-function manifests with a
cutaneous phenotype.
The allocrite of ABCA5 has remained unknown, however, we
have observed a cholesterol transport defect in human CGHT
keratinocytes and mouse Abca5 has previously been reported to
play a role in cholesterol efflux in macrophages [16]. In rats and
now mice, Abca5 localizes to the Leydig cells of the testis, a
primary site for cholesterol processing and sterol hormone
synthesis [21], suggesting cholesterol is a potential allocrite for
this transporter. Importantly, these reports as well as the
subcellular localization pattern of Abca5 are consistent with our
observation that ABCA5 deficiency in CGHT patient cells causes a
redistribution of free cholesterol and accumulation of this sterol in
the endolysosomal compartment. The resulting sequestration of
cholesterol within these organelles may prevent the delivery of this
essential lipid to other cellular compartments, such as the plasma
membrane, altering their physical and signaling properties.
Alternatively, accumulation of endolysosomal cholesterol may
decrease the overall fitness of these organelles, leading to a
decrease in the degradative capacity of lysosomes and causing
secondary defects in autophagy.
Cholesterol as a covalent modification is required for the
biological activity of several signaling proteins in the Wnt and Shh
pathways that regulate hair follicle morphogenesis and cycling
[48]. Overexpression and knockout mouse models for such
molecules have demonstrated critical roles in hair follicle
patterning and possess phenotypes reminiscent of hypertrichosis.
For example, mice deficient for the Smoothened (Smo) gene in Keratin-
14-expressing epithelia develop de novo and abnormally large hair
follicles from increased mesenchymal SHH signaling [49], and the
overexpression of a stabilized beta-catenin (Ctnnb1) induces early
placode formation as well as an increased density of hair follicles
[50]. We postulate that decreased free cholesterol in ABCA5
deficient CGHT cells may modulate the range and/or morpho-
genetic activity of such proteins either in the epithelium or
mesenchyme during hair follicle patterning. Future experiments
employing lineage-specific deletions of ABCA transporters (i.e.
Abca1, Abca5) will be useful in testing this, where free cholesterol
levels can be measured biochemically and by filipin immunostain-
ing, followed by a thorough analysis of hair follicle morphology
and density. Similarly, a pharmacological approach to deplete
sterols (i.e. cyclodextrin treatment) or block ABCA transporter
activity (i.e. glyburide treatment) in pregnant dams during hair
follicle morphogenesis may provide insight into the role of
cholesterol transport in hair patterning and growth.
In mice, the biogenesis of cholesterol and other lipids has been
shown to play a role in regulating hair growth, as mice deficient for
Stearyl-CoA Desaturase I (SCD1), the enzyme required for the
biosynthesis of monounsaturated fatty acids that compose choles-
terol esters as well as membrane phospholipids and triglycerides,
develop alopecia and possess a sparse hair coat with dry, scaly skin
[51] – [53]. Furthermore, topical treatment of mouse skin with a
cholesterol biosynthesis inhibitor of a sterol precursor leads to hair
loss through the induction of catagen [54]. It remains to be
determined whether Abca5-/- mice possess a hair phenotype, since
this has not been directly examined and hair phenotypes in mutant
mice deficient for several factors can be subtle in the absence of
detailed histological analysis [55]. If hair patterning is aberrant in
Abca5-/- mice, lineage-specific deletions of Abca5 followed by
morphometric and densitometric analysis of hair follicles may
provide insight into the target cell type underlying the pathology in
CGHT.
In the sporadic CGHT case, we found that ABCA5 transcripts
were significantly reduced. One possible explanation for this is that
a trans mechanism for regulating ABCA5 gene expression via an
enhancer or some other regulatory element is in place, such that
deletion of one copy of ABCA5 and its regulatory elements
abrogates gene expression on the other allele. Conversely, ABCA5
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may be imprinted or expressed preferentially from one allele, in
which case, deleting the transcriptionally-active allele would result
in loss of gene expression, thereby recapitulating the phenotype of
the loss-of-function mutation. Alternatively, ABCA5 may be a
dosage-sensitive gene, where altering the copy number is sufficient
to produce a phenotype, but perhaps in a distinct manner from the
loss-of-function mutation identified in the present study, since
carriers are unaffected. Since we observed a decrease in SOX9
expression in sporadic CGHT patient keratinocytes, consistent
with our previous findings in an autosomal dominant CGHT case
[4] and considering the known role of SOX9 in hair follicle stem
cells [30], [31], it is likely that the excessive hair overgrowth
phenotype observed in sporadic CGHT may be the result of
reduced levels of both ABCA5 and SOX9 transcripts. We did not
detect altered SOX9 expression in the autosomal recessive CGHT
case, suggesting either that SOX9 acts upstream of ABCA5 or that
the two genes reside in separate pathways, employing distinct
mechanisms to contribute to the CGHT pathology.
Importantly, this is the first report of the ABCA5 gene to be
associated with a human genetic condition, and the first reported
case of CGHT in which a point mutation in a single gene
contributes to the excessive hair overgrowth phenotype. Collec-
tively, our findings provide insight into the mechanisms by which
ABCA5 may directly or indirectly act to control hair growth at the
subcellular level. While there is evidence to support a role for
ABCA5 in both epithelial and mesenchymal compartments of the
hair follicle, the precise cell type(s) deficient for ABCA5 that is
associated with excessive hair overgrowth remains unclear. In light
of our findings, we postulate that the loss-of-function of ABCA5
during morphogenesis abrogates lysosome function and cholesterol
efflux in hair follicle cells, leading to the aberrant activity of one or
more downstream signaling pathways with crucial, defined roles in
hair follicle induction, development and cycling.
Materials and Methods
Ethics statement
Informed consent was obtained from all subjects and approval
for this study was provided by the Institutional Review Board of
Columbia University in accordance with the Declaration of
Helsinki Principles.
Patient information and materials
In the autosomal recessive CGHT case, the proband is an
eleven-year-old girl with congenital generalized hypertrichosis
segregating with gingival hyperplasia and epilepsy. She was the
product of a full-term uncomplicated pregnancy to a then 18-year
old Yemeni mother whose husband is her first cousin. The
patient’s initial genetic evaluation was at 6 months of age;
chromosome analysis revealed 46, XX normal complement and
SNP arrays revealed multiple regions of homozygosity consistent
with parental consanguinity. Severe hypertrichosis and a low
anterior hairline that merged with the eyebrows were observed,
and excessive body hair was present on the patient’s back and
extremities, as well as on the upper lip, genitalia, and axillary
regions. Hair overgrowth progressed on her face trunk, eyebrows
and eyelashes, and scalp as well as body hair is long and coarse.
The gingival hyperplasia became evident at 18 months of age and
progressed to the extent that it interfered with tooth eruption and
feeding. Partial gum surgical resection was initially performed at 3
years of age and has been performed several additional times over
the past eight years due to excessive gum overgrowth. Extensive
endocrine and metabolic workups have been performed over the
years and all results have been normal.
In the sporadic CGHT case, the patient initially presented to
the clinic at the age of three months. On physical exam, she had
universal hypertrichosis that was accentuated on the extremities,
the back, chest, and the face. As expected, regions that are devoid
of hair follicles including the palms, soles and distal phalanges were
spared. In addition, the patient had unusual facial features,
including a broad base of the nose, widely set eyes, and bulbous tip
of the nose. The parents reported that the excessive body hair was
shed during the first month of life, but then grew back with
increased length. The mother did not report any drug intake,
major illness or trauma during pregnancy, and the girl was born at
full term. There is no history of hypertrichosis in the family.
Extensive physical examination, radiological studies including X-
rays (skull, long bones and hands), laboratory evaluations
(complete blood count, blood chemistry, general urine examina-
tions) and abdominal ultrasonography did not reveal any
abnormalities.
In the autosomal recessive CGHT case, two small punch
biopsies from extensor skin of the extremities, 3–5 cc of blood, in
addition to plucked hairs from the forearm were received from the
proband (II-1) and the unaffected father (I-1). For each individual,
one biopsy was divided into two pieces: one flash frozen for RNA
extraction and the other embedded in OCT for histological and
immunological analyses. The other piece of whole skin was used
for the culturing of keratinocytes and fibroblasts. In the sporadic
CGHT case, a skin biopsy from the back of the affected individual
was obtained; 3–5 cc of blood for DNA and RNA extraction was
also obtained from the patient and her unaffected parents. Control
hair follicles used in expression studies were obtained either from
forearm skin biopsies or from occipital scalp biopsies, designated as
non-human subject research under 45 CFR Part 46 and therefore
IRB exempted for research.
Whole-exome sequencing
Full exome sequencing, bioinformatics analysis (consisting of
initial data processing, base calls, alignments, variant calls,
nucleotide and amino acid conservation, biochemical nature of
amino acid substitution, population frequency, and predicted
functional impact), and filtering based on autosomal and X-linked
dominant and recessive inheritance models was performed on the
autosomal recessive CGHT case using genomic DNA from the
proband (II-1), the unaffected mother (I-2), and the unaffected
father (I-1) through Ambry Genetics (Allso Viejo, CA). Evaluation
of relationships between the proband and unaffected parents was
performed using Short Tandem Repeat markers and samples were
prepared using the SureSelect Target Enrichment System (Agilent
Technologies). In brief, genomic DNA was sheared, adaptor
ligated, and PCR amplified, followed by incubation with the
exome baits, elution, and then PCR amplification. Libraries were
generated, quantified, and hybridized to the Illumina HiSeq 2000
flow cell for paired-end sequencing. Bioinformatics analysis was
used for initial data processing, base calls, alignments as well as
variant calls, and the Ambry Genetics Variant Analyzer tool
(AVA) was used to determine conservation of nucleotide and
amino acids as well as biochemical nature of substitutions,
population frequency, and predicted functional impact. Various
genome databases (Human Genome Mutation Database
(HGMD), HapMap data, Single Nucleotide Polymorphism
database (dbSNP), 1000 genomes) were used to search for
previously described mutations and/or polymorphisms, and co-
segregation studies were performed for candidate gene mutations.
Full-exome sequencing revealed a total of 53 genes (85 alterations),
and filtering based on the following criteria was used: deleterious
nature of the alteration (34 genes, 5 unique alterations), removal of
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alterations clearly unrelated to patient’s phenotype (26 genes, 33
alterations), and further interpretive analysis based on literature
searches for genotype-phenotype correlation resulted in the
selection of 3 genes (3 alterations) for further investigation.
Nucleic acid extraction and sequencing
Genomic DNA was isolated from whole blood of the proband (I-
1) and father (II-1) from the autosomal recessive CGHT case as well
as from the patient with sporadic CGHT. Total RNA was extracted
from forearm skin biopsies as well as from cultured keratinocytes
and fibroblasts from family members I-1 and II-1 using the Qiagen
RNeasy RNA extraction kit and standard methods.
PCR amplification of the exon 32-intron 32 boundary was
performed in the autosomal recessive CGHT case using standard
conditions and the following primers: F: 59-GAACATCTTCA-
GAAGACTGTAAAG-39 and R: 59- GTAATCTGAGGATTC-
CCTAGCATAC -39. To amplify and sequence the mutant ABCA5
transcript, the following primers were used: F (in Exon 28): 59-
GCTGATGGGTTGCCAGTGTTGTGAAG-39, and R (in Exon
33): 59-CACATGTGCTGTTTGGCTTTGGGATC-39. For se-
quencing of ABCA5 in the sporadic CGHT case, 100–200 ng
gDNA was used and primers were designed to flank the intron-
exon boundaries 100–150 bp from each exon.
Quantitative PCR on genomic DNA and quantitative RT-
PCR on RNA
Quantitative PCR was performed on genomic DNA from the
sporadic CGHT case to confirm the 1.3 Mb deletion identified; three
amplicons on chromosome 17 were tested using Relative Quantifi-
cation and the following primers: Amplicon 1 (chr17: 66639201-
66639359, 159 bp): F: 59-TAGATCATTCTCCTAAATGCTCT-
TCC -39, R: 59-GATGCAGCAAAGTTCTCAGGTG -39; Ampli-
con 2 (chr17: 66958719- 66958932, 214 bp): F: 59- GCTGAGCC-
TCTCCTGAAAACTGGACAAC -39, R: 59- GACTCAACTGA-
CATAGGCCATGACAG -39; Amplicon 3 (chr17: 67249799-
67249985, 213 bp): F: 59- GAACATCTTCAGAAGACTGTAA-
AG -39, R: 59- CTGAGGATTCCCTAGCATACTTAGAGC -39.
Amplicon 4 (chr17: 67716661- 67716904, 244 bp): F: 59- AC-
CATGTAAACAAGGAAAACAAC -39, R: 59- CTGAGGATT-
CCCTAGCATACTTAGAGC -39. Amplicon 5 (chr17: 68403395-
68403416, 244 bp): F: 59- CATTTATCCATATGGGAGGTAG -
39, R: 59- AACAGATGTCCAAGAGAGTCAAATC -39. Values
were normalized to the b2M amplicon (161 bp) using the following
primers: F: 59- CACCTATCCCTGTTGTATTTTATCG -39, R:
59-CTCTTTATTTCTGCTGAGGTTTT-39. All coordinates ref-
erence UCSC human reference genome build hg19.
Quantitative RT-PCR was performed on RNA isolated from
whole skin, cultured keratinocytes and fibroblasts as previously
described [5], [10] and as per the manufacturer’s instructions.
Relative quantification using the ddCT method [56] was
performed with the b2M gene as the housekeeping control. The
following primers were used for qRT-PCR assays: ABCA5: F: 59-
GAACCAACTTCAGGCCAGGTATT-39, R: 59-CACATGTG-
CTGTTTGGCTTTGGGATC -39; b2M: F: 59-GAGGCTATC-
CAGCGTACTCCA -39, R: 59- CGGCAGGCATACTCATCT-
TTT-39; SOX9: F: 59- AGTACCCGCACTTGCACAA-39, R: 59-
CCGTTCTTCACCGACTTCCT-39. GAPDH: F: 59-GGAGC-
GAGATCCCTCCAAAAT -39, R: 59- GGCTGTTGTCATA-
CTTCTCATGG-39
Statistical analysis
All experiments were performed in triplicates using materials
from affected, carrier and control individuals. Experiments were
repeated in triplicates, and a Student unpaired t-test was used to
determine statistical significance in qPCR and qRT-PCR exper-
iments with a p value of 0.05 as the cutoff value for significance.
For autophagy experiments, quantification statistical analysis was
performed using a two-tailed, equal variance Student’s t-test. P-
values of ,0.05 (*), ,0.01 (**), ,0.001 (***) were determined to
be statistically significant. The number of cells analyzed per
condition is as follows: control, no bafilomycin: 61 cells; control,
bafilomycin: 63 cells; affected, no bafilomycin: 37 cells; control,
bafilomycin: 43 cells.
Isolation and culturing of human keratinocytes and
fibroblasts from whole-skin biopsies
Keratinocytes and fibroblasts were isolated and cultured from
whole skin biopsies for the proband (I-1) and unaffected father (II-
1) from the first case, and the patient from the second sporadic
CGHT case using the method described in [10].
In situ hybridization and immunohistochemical staining
on whole skin
The DIG labeling system (Roche) was used to construct the
sense and antisense riboprobes for hABCA5 sequences, amplified
using the following primers: hABCA5 (Exon 13–19, 812 bp): F: 59-
GTGCAGAAGGTTTTACTAGATTTAGACA-39, R: 59- GTC-
TGGAACAAGTTTGATGGGAACCAC-39; hABCA5 (Exon 28–
33, 550 bp): F: 59-GCTGATGGGTTGCCAGTGTTGTGAAG-
39, R: 59-CACATGTGCTGTTTGGCTTTGGGATC -39. For
human expression studies, in situ hybridization was performed on
10 mM skin and hair follicle sections from control, carrier and
affected individuals using the methods described in [10].
Immunohistochemistry was performed on formalin-fixed par-
affin-embedded (FFPE) sections of whole skin and hair follicles. In
brief, slides were deparaffinized and rehydrated with a series of
ethanol washes and then with 1X TBS. Antigen retrieval was
performed for 10 minutes in a 1M sodium citrate, pH 6.0
solution heated to 95uC, and then slides were cooled and washed
three times in 1X TBS. Tissues were blocked in either 10%
normal donkey serum (Jackson ImmunoResearch, PA, USA) or
2% fish skin gelatin (Sigma Aldrich, MO, USA) and incubated
with primary antibody in 1X TBS at 4uC overnight. The anti -
rabbit ABCA5 antibody (ab99953, Abcam) was used at a
concentration of 1:200 and the anti -rabbit IgG isotype primary
antibody (Santa Cruz Biotechnologies, CA, USA) control was
used at the same concentration. Slides were then washed with 1X
TBS, incubated with the goat anti -rabbit biotin-conjugated
antibody (1:800 in 1X TBS) for an hour at room temperature,
washed again with 1X TBS and then incubated with the
streptavidin-alkaline phosphatase (AP) tertiary antibody (Invitro-
gen; 1:300 in 1X TBS) for 30 minutes at room temperature. The
SIGMA FAST Fast Red TR/Naphthol AS-MX Tablets (Sigma
Aldrich, MO, USA) were used to develop the slides, which were
then mounted with Dako Glycergel Mounting Medium (Dako,
CA, USA).
Immunofluorescence staining and immunoblotting
Immunofluorescence staining was performed on whole skin
10 mm sections from both human and mouse embedded in
Optimal Cutting Temperature (O.C.T.). Slides were fixed with
50%MeOH/50% Acetone for 10 minutes at220uC, washed with
1X PBS, and then blocked with 2% fish skin gelatin (Sigma
Aldrich, MO, USA). The ABCA5 (Abcam, ab99953) and anti-
rabbit IgG (Santa Cruz Biotechnologies) primary antibodies were
used at a concentration of 1:200. Slides were then washed,
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incubated with the Alexa Fluor 488 donkey anti-rabbit IgG
(Molecular Probes, Invitrogen) secondary antibody (1:800 in 1X
PBS), mounted with VECTASHIELD mounting medium with
DAPI (Vector Laboratories, Burlingame, CA, USA), and imaged
using a LSM 5 laser-scanning Axio Observer Z1 confocal
microscope (Carl Zeiss).
For autophagy analysis, human keratinocytes were grown to
confluence, seeded on 12 mm coverslips, and then fixed with 4%
paraformaldehyde for 20 min at room temperature. After
permeabilization with 200 mg/ml digitonin (Invitrogen) in PBS
for 10 min, cells were incubated with the specified primary
antibodies for 1 hr at room temperature. Subsequently, cells were
incubated with the appropriate Alexa-Fluor-conjugated secondary
antibodies for 1 hr at room temperature, for cholesterol staining
cells were additionally incubated with Filipin complex (Sigma) for
1 hr at room temperature. Images were acquired by confocal laser
scanning microscopy (Zeiss LSM-700) and analyzed with Zeiss
Zen and ImageJ Software (NIH). The number of LC3-positive
compartments and their surface areas (expressed as number of
pixels per field) were normalized to the number of cells in each
field. The average size was obtained by dividing the surface area of
the LC3-positive compartment (in pixel2) by the number of LC3
puncta. Similar measurements were made for Lamp1 and p62
compartments. Primary antibodies used for immunofluorescence:
mouse anti-LC3 (MBL), guinea pig anti-p62 (Progen), rabbit anti-
Lamp1 (Abcam) mouse anti-Lamp2 (Santa Cruz). Bafilomycin A1
(50 nM, Wako) was added to the media 2 hours prior to cell
fixation.
Immunoblotting was performed using 10 mg total protein
extracted with RIPA buffer/proteinase inhibitor cocktail from
cultured keratinocytes and fibroblasts and SDS-PAGE was used to
separate proteins, followed by a wet transfer to a hybond ECL
nitrocellulose (Amersham, NJ, USA) or PVDF membrane
(BioRad, CA, USA) membrane. All membranes were blocked
with 5% milk for one hour at room temperature and then
incubated with the primary antibodies, ABCA5 (1:500) and beta-
actin (1:1000; Santa Cruz Biotechnologies, CA, USA) diluted in
Washing Buffer (1X PBS 0.1% Tween-20). Membranes were then
washed several times in 15-minute intervals with 1X PBST,
incubated with goat anti-rabbit or mouse- HRP conjugated
secondary antibody (Invitrogen; 1:1000), and then developed with
the SuperSignal West Dura Extended Duration Substrate
(Thermo Scientific, IL, USA).
Cytogenetic analyses
G-banding analysis was performed using standard techniques,
and FISH using chromosomal paint was performed on metaphase
chromosomes obtained from peripheral blood leukocytes (PBLs),
as per the manufacturer’s directions (VYSIS). Sub-telomeric FISH
was performed using a mixture of probes for chromosomes 17q,
17centromere, 9p, and 9q obtained from VYSIS in accordance
with the manufacturer’s instructions. Chromosomes were coun-
terstained with DAPI (VYSIS) and hybridized metaphase chro-
mosomes were viewed using a Nikon microscope fitted with a filter
wheel and Cytovision Applied Imaging software.
Breakpoint mapping and copy number variant (CNV)
analysis
Breakpoint mapping was performed using FISH with BAC
clones in the chromosome 17q24 region. To fine map the deleted
region on chromosome 17q, genome scanning was initially
performed using the Affymetrix 500k whole-genome mapping
array, and then the 2.7M array (Affymetrix) to further examine
CNVs in the region of the breakpoint.
Supporting Information
Figure S1 Histological analysis of CGHT and control hair
follicles by hematoxylin and eosin staining. (A–C) Hematoxylin
and eosin staining of a patient skin biopsy from the forearm
demonstrated that hair follicles are of the terminal type, as they are
medullated, pigmented, and penetrate deep in the dermis. (B)
Enlarged image of a late catagen hair follicle. (C) Magnified image
of an anagen hair follicle situated deep in the dermis (A). Note the
thickness of the outer root sheath compared to control hair follicles
(D–F). (D) Hematoxylin and eosin staining of a control skin biopsy
from the forearm. (E) Magnified image of a hair in catagen. (F)
Enlarged image of the apoptosing strand of the catagen hair
follicle. Note the size of the control hair follicle compared to
patient hair follicles. No anagen hair follicles were present in the
control skin biopsy. DS = dermal sheath; PFD = perifollicular
dermis; IRS = inner root sheath; ORS = outer root sheath; HS
= hair shaft; SG = sebaceous gland; DP = dermal papilla.
(TIF)
Figure S2 Mouse Abca5 localization pattern in the adult testis
and epididymis by immunohistochemistry and immunofluores-
cence staining. (A, B) Immunohistochemistry on formalin-fixed
paraffin-embedded (FFPE) adult mouse testis demonstrated strong
localization of Abca5 to the basal cells of the seminiferous tubules
(arrows in (A)), interstitial space consisting of Leydig cells, and
tunica albuginea (arrow in (B)). (D, E) Abca5 immunohistochem-
istry on formalin-fixed paraffin-embedded adult mouse epididymis
revealed strong localization to the connective tissue, smooth
muscle cells and fibrocytes surrounding the cylindrical epithelium
within the corpus and cauda regions, as well as within the basal
and tall columnar cells of the cauda cylindrical epithelium (E). (C,
F) Testis and epididymis sections incubated without primary
antibody produced no signal. (G–I) Immunofluorescence staining
of Abca5 in the testis and epididymis demonstrated Abca5
localization to the same structures within the testis and epididymis
as did the immunohistochemical staining method.
(TIF)
Figure S3 Mouse Abca5 localizes to the outer and inner root
sheath of anagen hair follicles. (A, B) Immunofluorescence staining
of Abca5 on frozen mouse anagen skin (day 30) sections
demonstrated a signal only within hair follicles (A), specifically
within the outer and inner root sheath (B, C). (E–F) Immunohis-
tochemical staining on formalin-fixed paraffin-embedded (FFPE)
anagen skin sections revealed Abca5 localization to the outer and
inner root sheath, and some signal present in the follicular dermis
including the dermal sheath. No signal was observed on sections
incubated without primary antibody (D, G).
(TIF)
Figure S4 Immunoblotting on protein extracted from carrier
and patient fibroblasts in the presence of absence of the enzyme,
PNGaseF that removes all N-glycosyl modifications revealed loss of
a ,100 kDa band that is the glycosylated form of the protein in
the patient relative to the carrier. b-actin was used as a loading
control.
(TIF)
Figure S5 Quantification of immunofluorescence staining for
LC3 and p62 reveals defective autophagic clearance in CGHT. (A)
The formation of LC3 puncta was significantly increased in
affected vs. control keratinocytes (p,0.05, – Bafilomycin; p,0.01,
+ Bafilomycin) as well as within control keratinocytes +
Bafilomycin vs. – Bafilomycin treatment (p,0.01), but no
significant difference was observed between affected keratinocytes
+ Bafilomycin vs. – Bafilomycin treatment. (B) The formation of
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p62 puncta was significantly increased in affected vs. control
keratinocytes (p,0.01) as well as within control keratinocytes +
Bafilomycin vs. – Bafilomycin treatment (p,0.01), but no
significant difference was observed between affected keratinocytes
+ Bafilomycin vs. – Bafilomycin treatment. A Student t test
(unpaired) was performed with a cutoff P value of 0.05 for
statistical significance and error bars represent the standard
deviation. ImageJ was used for image quantification.
(TIF)
Figure S6 Histological analysis of hair follicles from the sporadic
CGHT case. Hematoxylin and eosin staining of a patient skin
biopsy from the lower back reveals the presence of terminal hair
follicles in the anagen stage. DS = dermal sheath; PFD =
perifollicular dermis; IRS = inner root sheath; ORS = outer root
sheath; HC = hair canal; SG = sebaceous gland.
(TIF)
Figure S7 Telomere FISH and FISH using BAC clones
spanning chromosome 17q24.2-24.3 to detect the 1.3 Mb cryptic
deletion in sporadic CGHT. (A) Telomere FISH was performed to
test possible deletions at the end of chromosome 17q using a
commercially available probe mix for 17q (green), 17 centromere
(green), 9p (green), and 9q (red). Note the presence of the green
signal on the derived chromosome 3 indicating that the telomere
of chromosome 17 was not deleted in the t3;17 rearrangement. (B–
C) FISH using BAC clones on chromosome 17q24.2-q24.3
revealed a cryptic deletion at the breakpoint of chromosome 17.
Metaphase spreads and interphase nuclei show only one signal for
clones RP11-387O17 (green) (B) and RP11-293K20 (green) (C),
which hybridize to the deleted 1.3 Mb portion of chromosome
17q24.2-24.3.
(TIF)
Figure S8 Summary of CNVs within the chr17q24.2-24.3
region identified in autosomal dominant and sporadic cases of
CGHT illustrates that ABCA5 is located in the minimal common
region. ABCA5 (red box) and the other genes in the surrounding
region (black boxes) as well as direction of transcription (arrows)
are indicated. Nature of the variants (duplications, deletions)
previously reported as well as identified in this study is indicated as
well as the sizes and corresponding references. qPCR amplicons
are represented by vertical lines, where two amplicons flank the
1.3 Mb deleted region (red box) and three amplicons lie within it.
Database of Genomic Variants (DGV) alterations are indicated as
gray boxes. All variants lie 1–2 Mb upstream of the SOX9 gene.
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